KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, today announced that the company will be webcasting its corporate presentation at the Oppenheimer 26th Annual Healthcare Conference on Tuesday, December 8, 2015 at 1:00 p.m. EST in New York.
